Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
This clinical trial update outlines a study evaluating gastrointestinal cancer biomarkers in tissue and biological fluids from colorectal ca…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: FAZA PET/MRI Pancreas [NA]
A FAZA PET/MRI imaging study for pancreatic cancer that is unresectable or locally advanced is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: ctDNA Assay in Patients With Resectable Pancreatic Cancer
This clinical trial update describes an ongoing study evaluating a circulating tumor DNA (ctDNA) assay in patients with resectable pancreati…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
This update covers the INSPPIRE 2 study, a pediatric biospecimen collection effort to identify gene mutations associated with high-risk panc…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Expanded access (compassionate use) for the DNG64-CAR-V cell therapy in patients with advanced pancreatic cancer, various sarcoma subtypes, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
A planned clinical trial uses endoscopic ultrasound-guided circulating tumor cells combined with multi-omics to predict recurrence and metas…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer [Phase 3]
Phase III study evaluating Ivonescimab plus chemotherapy with or without AK117 in metastatic pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies [Phase 2]
A Phase 2 clinical trial update evaluating tunlametinib in combination with an anti-EGFR monoclonal antibody for RAS-mutated advanced colore…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Surgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)
Clinical trial assessing surgical management of pancreatic cancer with liver metastases (oligometastasis) has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
A Mayo Clinic–sponsored Phase 2 trial evaluating standard chemotherapy with or without stereotactic body radiation therapy for oligometastat…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating AK130 in combination with AK112 for advanced pancreatic cancer is currently in the recruitment phase.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) [Phase 1, Phase 2]
Phase I/II trial of nab-paclitaxel plus gemcitabine with proton therapy for locally advanced pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
This entry notes a Johns Hopkins University-sponsored study evaluating diagnostic strategies, risk assessment, and progression of pancreatic…
-
CLINICAL_TRIALS other · 2026-03-02Clinical Trial Update: Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.
An administrative clinical trial update about patients undergoing pancreatic surgery at Antwerp University Hospital, covering benign and mal…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial update for Tele-PancFit, a multi-site video-based prehabilitation program aimed at improving strength before pancreatic canc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating hV01, a recombinant human IL-21-expressing oncolytic vaccinia virus, for advanced pancreatic cancer is c…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide [EARLY_Phase 1]
First-in-human Phase 1 PET imaging study of the 18F-αvβ6-binding peptide, a radiotracer targeting αvβ6, is active but not currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury [Phase 2]
Phase 2 clinical trial evaluating the PET imaging probe [68Ga]CBP8 for detecting radiation-induced tissue injury in patients with lung and p…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
This document provides an update on a completed study examining the clinical, radiologic, pathologic, and molecular marker characteristics o…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: AI-Powered Precision Decision-Making for Pancreatic Diseases
An ongoing clinical trial evaluating AI-powered precision decision-making for pancreatic diseases. Recruitment is currently in progress.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer [NA]
A clinical trial at Ohio State University is evaluating DCE-MRI guided neoadjuvant chemotherapy for borderline-resectable pancreatic cancer …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial is planned to compare surufatinib plus gemcitabine and nab-paclitaxel against gemcitabine and nab-paclitaxel as neoadjuvant …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating EDV Nanocell Therapy in combination with gemcitabine and nab-pacli…